This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

/C O R R E C T I O N -- Divine Skin Inc./

In the news release, Biotech Pioneer Divine Skin Says Q3 Revenue Jumps to Roughly $1.6 Million, up 23% From Q3 and Soars 75% From Last Year, issued 05-Oct-2010 by Divine Skin Inc. over PR Newswire, we are advised by the company that the headline and first paragraph, first sentence, should read "Q2" rather than "Q3" as originally issued inadvertently. The complete, corrected release follows:

Biotech Pioneer Divine Skin Says Q2 Revenue Jumps to Roughly $1.6 Million, up 23% From Q2 and Soars 75% From Last Year

MIAMI BEACH, Fla., Oct. 5 /PRNewswire-FirstCall/ -- Rapidly expanding biotech developer Divine Skin Inc. (OTC Bulletin Board: DSKX) announced preliminary Q2 numbers today: $1.6 million or 23 percent above the previous quarter and 75 percent above Q3 of last year.

"Sustained growth over several quarters demonstrates the viability of our core principles of cutting-edge product development and absolute dedication to servicing our customers. We are also most excited about the release of Revita.COR conditioner which we believe establishes new possibilities in biotech development" said co-founder and chief executive Daniel Khesin, whose company maintains edge-of-the art development of new molecules and therapies in the personal care sector. The company maintains its position as the world's innovator of hair re-growth technologies.

Revenue has been driven by new distribution and new products.

The Sigma Skin brand is already present in the majority of Neiman Marcus stores, the premier luxury retailer in the USA. The brand will continue to proliferate through the rest of the network as planned.  

The DS Laboratories brand has continued to implement its deal with Fantastic Sams, stocking shelves and training employees for the chain of 1,300 franchised salons. DS Laboratories is on track to roll out in the rest of the chain by the end of the year. Demand has exceeded expectations through existing Fantastic Sams retail doors.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.64 0.00%
FB $118.57 0.00%
GOOG $698.21 0.00%
TSLA $241.80 0.00%
YHOO $36.53 0.00%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs